Riskpilot← Back to searchSign inGet full accessNORDKAPP FIRST AID AS
ASActiveOrg 922652139Sønsterudveien 26, 1412 SofiemyrWholesale of pharmaceutical and medical goods · NACE 4646Est. 20190 employees
Revenue 2024
NOK 1,5M
+84% vs 2023
EBITDA margin
-23.0%
-148% vs 2023
Equity ratio
8.0%
Financial strength
Net profit 2024
NOK -452K
-178% vs 2023
| Revenue | NOK 1,5M | +84% |
| EBITDA | NOK -356K | -148% |
| Net profit | NOK -452K | -178% |
| Total assets | NOK 1,5M | +15% |
| Equity | NOK 118K | -79% |
| Employees | 0 | — |
Legal name
NORDKAPP FIRST AID AS
Org number
922652139
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23. april 2019
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Salg og distribusjon av førstehjelpsutstyr og det som følger med samt alt annet som hørere naturlig til
Address
Sønsterudveien 26, 1412 Sofiemyr
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 840 | 1 549 |
| Staff expenses | −0 | −0 | −0 | −0 | −107 |
| EBITDA | −7 | −10 | −9 | 740 | −356 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −96 |
| EBIT | −7 | −10 | −9 | 740 | −452 |
| Net financials | 0 | 0 | 0 | −3 | 0 |
| Profit before tax | −7 | −10 | −9 | 737 | −452 |
| Tax | −0 | −0 | −0 | 159 | −0 |
| Net profit | −7 | −10 | −9 | 578 | −452 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 941 | 16 | 7 | 1 272 | 1 465 |
| Equity | 12 | 2 | −8 | 570 | 118 |
| Long-term debt | 929 | 0 | 0 | 480 | 520 |
| Short-term debt | 0 | 15 | 15 | 222 | 827 |
| Total debt | 929 | 15 | 15 | 702 | 1 348 |
EBITDA margin
-23.0%
This company
15.8%
Market median
-246% vs market
20202024
Equity ratio
8.0%
This company
38.2%
Market median
-79% vs market
20202024
Return on equity
-384.6%
This company
18.4%
Market median
-2190% vs market
20202024
Net profit margin
-29.2%
This company
8.1%
Market median
-460% vs market
20202024
Asset turnover
1.06×
This company
1.12×
Market median
+5% vs market
20202024
Debt / equity
11.46×
This company
0.62×
Market median
-1748% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BR Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
MS Chief Executive Officer | Chief Executive Officer | 2019 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2019 – 2023 | |
| Board of Directors | 2019 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORDKAPP FIRST AID AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Muhammad Saqib | Chief Executive Officer | 0 companies |
| Babar Razzaq | Chief Executive Officer | 0 companies |
| Yasar Ahsan | Board of Directors | 0 companies |
| Zeeshan Iqbal | Board of Directors | 0 companies |